Pennington Emily
Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic.
Cleve Clin J Med. 2020 May 5. doi: 10.3949/ccjm.87a.ccc002.
Current Centers for Disease Control and Prevention guidelines state that patients with moderate to severe asthma may be at greater risk for more severe disease if infected with SARS-CoV-2; however, no published data support this suggestion. During this pandemic, it is recommended that patients with asthma continue taking all controller inhalers and other asthma medication as prescribed to prevent exacerbations and limit outpatient clinic and emergency room exposure. Symptoms that may differentiate COVID-19 from asthma exacerbations caused by another trigger may include fever, fatigue, anorexia, or myalgias. Patients with suspected or confirmed COVID-19 should avoid nebulizer treatments due to the risk of aerosolization.
美国疾病控制与预防中心目前的指南指出，中度至重度哮喘患者若感染新冠病毒，可能面临更严重疾病的风险更高；然而，尚无公开数据支持这一说法。在此次疫情期间，建议哮喘患者继续按医嘱使用所有控制型吸入器和其他哮喘药物，以预防病情加重，并减少门诊和急诊室就诊次数。可能将新冠病毒感染与其他诱因导致的哮喘加重区分开来的症状包括发热、乏力、厌食或肌痛。疑似或确诊感染新冠病毒的患者应避免雾化治疗，因为存在气溶胶传播风险。
